Viral hepatitis is a common disease globally, but many are unaware of their status. Symptoms and transmission routes are discussed here.

Current therapies for chronic hepatitis B virus (HBV) infection can effectively suppress viral replication but do not achieve ...

Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for long-acting helicase-primase inhibitors ABI-5366 and ABI-1179 anticipated in fall ...

Title: ALG-055009, a potent and selective thyroid hormone receptor beta agonist for the treatment of metabolic ...

Nespresso unveils its Summer 2025 collection, setting the stage for a season of indulgence and unforgettable summer moments.

Assembly Biosciences, Inc.’s ASMB share price has dipped by 5.02%, which has investors questioning if this is right time to ...

Hepatitis D is a type of viral hepatitis that affects around 48 million people worldwide. It is less common than other types of hepatitis that you might be more familiar with. Hepatitis D is thought ...

A recent case has been reported in Medicine of a patient with generalized pustular psoriasis (GPP) and hepatitis B whose flares were successfully controlled with a single dose of spesolimab. The ...

Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for high unmet medical needs such as chronic hepatitis B virus infection ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...